What happened
The United Kingdom did what Vermont, Colorado, and California could not. It built a universal system: publicly financed, free at the point of use, covering everyone. It made the turn.
Then, in 2004, it launched the Quality and Outcomes Framework — the largest primary-care pay-for-performance programme in the world. The logic was reasonable and familiar: identify clinical targets that matter, measure whether practices hit them, and pay accordingly. Billions were spent.
When researchers eventually modelled the programme's cost-effectiveness, it produced an incremental cost-effectiveness ratio of roughly £49,362 per quality-adjusted life year — well above the £20,000 to £30,000 threshold the UK uses to decide what its health system should fund. The published conclusion was blunt: continuing the QOF was not cost-effective, and the country should either redesign it or pursue alternatives.
Where it broke
The QOF did not rebuild how care was delivered. It layered measurement and payment on top of the existing architecture and expected behaviour to follow.
It paid for targets hit, not for arcs completed. It rewarded a blood pressure recorded, a box ticked, a metric moved — the things that are easy to count — rather than the thing that actually produces health, which is a continuous relationship held over years toward a defined endpoint. It bought compliance with measurement. It did not buy care.
And note carefully what judged it. The instrument that found the QOF wanting was a cost-per-QALY threshold — a framework built to evaluate products. It was never designed to see what continuous primary care produces. So the QOF was scored by an instrument that could not have credited it properly even if it had worked.
What the model says
This case is essential to the record precisely because it is not a story about failing to start. It is a story about what happens after you start — and it prevents this section from collapsing into a naive conclusion that passing universal coverage solves the problem.
Universal coverage is necessary. It is not sufficient. You still have to rebuild delivery. And if you attempt to improve delivery by attaching incentives to an unchanged structure, you will spend enormous sums, fail your own cost-effectiveness test, and be told by your own analysis that the effort was not worth it.
The QOF is the most expensive demonstration available anywhere that you cannot buy your way to better delivery without changing the delivery. That is this framework's central claim, tested at national scale, at a cost of billions — and confirmed.
It also demonstrates the second half of the problem. Even a country that solved the political fight still measures the wrong thing. Aim a product-shaped instrument at a delivery system, and it will report that the delivery system is not worth funding. That is not a finding about care. It is a finding about the instrument.
The lesson
Making the turn is the beginning, not the end. Coverage without rebuilt delivery — measured by an instrument built for products — produces exactly what Britain got: enormous spending, a failing score, and an official conclusion that the effort was not worth the money. The turn has to be made twice. Once in who is covered, and once in how care is actually delivered and counted.